References
- Fan Y Zhang Q . Development of liposomal formulations: from concept to clinical investigations. Asian J. Pharm. Sci.8 (2), 81–87 (2013).
- Torchilin VP . Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov.4 (2), 145–160 (2005).
- Rowland RN Woodley JF . The stability of liposomes in vitro to pH, bile salts and pancreatic lipase. Biochim. Biophys. Acta620 (3), 400–409 (1980).
- Liu W Ye A Liu W et al. Behaviour of liposomes loaded with bovine serum albumin during in vitro digestion. Food Chem.175, 16–24 (2015).
- Ensign LM Cone R Hanes J . Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv. Drug Deliv. Rev.64 (6), 557–570 (2012).
- Hu S Niu M Hu F et al. Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media. Int. J. Pharm.441 (1–2), 693–700 (2013).
- Li H Song JH Park JS et al. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor. Int. J. Pharm.258 (1–2), 11–19 (2003).
- Manconi M Nacher A Merino V et al. Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation. AAPS PharmSciTech14 (2), 485–496 (2013).
- Smistad G B⊘yum S Alund SJ et al. The potential of pectin as a stabilizer for liposomal drug delivery systems. Carbohydr. Polym.90 (3), 1337–1344 (2012).
- Klemetsrud T Jonassen H Hiorth M et al. Studies on pectin-coated liposomes and their interaction with mucin. Colloids Surf. B Biointerfaces103, 158–165 (2013).
- Sugihara H Yamamoto H Kawashima Y et al. Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin. J. Liposome Res.22 (1), 72–79 (2012).
- Parmentier J Hofhaus G Thomas S et al. Improved oral bioavailability of human growth hormone by a combination of liposomes containing bio-enhancers and tetraether lipids and omeprazole. J. Pharm. Sci.103 (12), 3985–3993 (2014).
- Huang YB Tsai MJ Wu PC et al. Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin. J. Drug Target19 (8), 709–718 (2011).
- Gradauer K Barthelmes J Vonach C et al. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats. J. Control. Release172 (3), 872–878 (2013).
- Chen D Xia D Li X et al. Comparative study of Pluronic® F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats. Int. J. Pharm.449 (1–2), 1–9 (2013).
- Zhang X Wu W . Ligand-mediated active targeting for enhanced oral absorption. Drug Discov. Today19 (7), 898–904 (2014).
- des Rieux A Pourcelle V Cani PD et al. Targeted nanoparticles with novel non-peptidic ligands for oral delivery. Adv. Drug Deliv. Rev.65 (6), 833–844 (2013).
- Makhlof A Fujimoto S Tozuka Y et al. In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. Eur. J. Pharm. Biopharm.77 (2), 216–224 (2011).
- Zhang X Qi J Lu Y et al. Biotinylated liposomes as potential carriers for the oral delivery of insulin. Nanomedicine10 (1), 167–176 (2014).
- Agrawal AK Harde H Thanki K et al. Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration. Biomacromolecules15 (1), 350–360 (2014).